Physician profile
Sarah M Moore
NPI 1730369786
$4,208.14
in general payments reported to CMS, 2019-2025
11 companies · $323 in 2025
The $323 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.29 · 2020: $37.18 · 2021: $317 · 2022: $508 · 2023: $2,685 · 2024: $319 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,873 · Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,873.31 |
| Food and Beverage | $1,452.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,843.83 | 2021-2025 | Cvi Contact Lens, Misight Contact Lens, Biofinity Contact Lens |
| Glaukos Corporation | $320.88 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $235.11 | 2022-2025 | Infuse |
| Johnson & Johnson Vision Care, INC. | $219.73 | 2020-2024 | Acuvue |
| Kala Pharmaceuticals, INC. | $170.61 | 2021-2022 | |
| Alcon Vision LLC | $142.82 | 2021-2024 | Precision 1 |
| Abbvie INC. | $125.00 | 2023 | |
| Heru, INC. | $78.18 | 2022 | |
| Mallinckrodt Hospital Products INC. | $33.21 | 2025 | Acthar |
| Aerie Pharmaceuticals, INC. | $20.29 | 2019 | |
| Optos, INC. | $18.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.